Cobos-Quevedo OJ, Hernández-Hernández GA, Remes-Troche JM

Language: Spanish
References: 49
Page: 487-502
PDF size: 265.54 Kb.

ABSTRACT

Wheat is one of the most produced and consumed cereals worldwide because of its simplicity to be cultivated in different climatic conditions, its nutritional value and its organoleptic characteristics. Wheat, as barley and rye, contains a molecule which can potentially be toxic to some individuals, the gluten. Today gluten-related disorders represent a diagnostic and therapeutic challenge as they include diseases that can have complications and deleterious health effects such as celiac disease, to purely symptomatic situations such as non-celiac gluten sensitivity (NGCS). A high clinical suspicion, as well as knowledge in the interpretation of diagnostic tests (serology, biopsy and genetic testing) are required to have an appropriate approach. In Mexico it is estimated that 1% of the population suffers celiac disease, 0.7% wheat allergy and NGCS can vary from 1% to 25% in special populations (irritable bowel syndrome, dyspepsia). At present proven celiac disease patients must undergo a strict gluten-free diet for the potential risk of complications. On the other hand in patients with NGCS, although this type of diet is recommended, lack of adherence will only lead to symptomatic relapse. Moreover, although there is a great availability of gluten free diets and products, these are not recommended for the general population or in cases in who the diagnosis of some of the gluten-related disorders is not properly established.

REFERENCES

1. Fasano A, Sapone A, Zevallos V, Schuppan D. Nonceliac gluten sensitivity. Gastroenterology 2015;148(6):1195-204.

2. Gibson PR, Varney J, Malakar S, Muir JG. Food components and irritable bowel syndrome. Gastroenterology 2015;148(6):1158-74.

3. Gibson PR, Muir JG, Newnham ED. Other dietary confounders: FODMAPS et al. Dig Dis DOI 371401.

4. Piezak M. Celiac disease, wheat allergy, and gluten sensitivity: When gluten free is not a fad. JPEN J Parental Enterol Nutr 2012;36(suppl 1):68S-75S.

5. Catassi C, Gatti S, Fasano A. The new epidemiology of celiac disease. J Pediatr Gastroenterol Nutr 2014;59(Suppl 1):S7-9.

6. Fasano A, Catassi C. Clinical practice. Celiac disease. N Engl J Med 2012 20;367(25):2419-26.

7. Valenta R, Hochwallner H, Linhart B, Pahr S. Food allergies: the basics. Gastroenterology 2015;148(6):1120-31.

8. Catassi C, Bai JC, Bonaz B, Bouma G, et al. Non-celiac gluten sensitivity: the new frontier of gluten related disorders. Nutrients 2013;5(10):3839-5.

9. Ludvigsson JF, Leffler DA, Bai JC, Biagi F, et al. The Oslo definitions for coeliac disease and related terms. Gut 2013;62:43-52.

10. Kelly CP, Bai JC, Liu E, Leffler DA. Advances in diagnosis and management of celiac disease. Gastroenterology 2015 May;148(6):1175-86.

11. Rubio-Tapia A, Hill ID, Kelly CP, Calderwood AH, Murray JA; American College of Gastroenterology. ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol 2013 May;108(5):656-76.

12. Sotelo Cruz N, Calderón de la Barca AM, Hurtado Valenzuela JG. Celiac disease in children from the northwest of Mexico: clinical characteristics of 24 cases. Rev Gastroenterol Mex 2013;78(4):211-8.

13. Gray AM, Papanicolas N. Impact of symptoms on quality of life before and after diagnosis of celiac disease: results of a UK population survey. BMC Health Serv Res 2010;10:105.

14. Volta U, Bardella MT, Calabrò A, Troncone R, Corazza GR; Study Group for Non-Celiac Gluten Sensitivity: An Italian prospective multicenter survey on patients suspected of having non-celiac gluten sensitivity. BMC Med 2014;12:85.

15. Sanders DS, Aziz, I. Non celiac wheat sensitivity: Separating the wheat from the chaff. Am J Gastroenterol 2012;107:1908-1912.

16. Sapone A, Bai JC, Ciacci C, Dolinsek J, Green PH, Hadjivassiliou M, et al. Spectrum of gluten-related disorders: Consensus on new nomenclature and classification. BMC Med 2012;10:13.

17. Marcason W.Is there evidence to support the claim that a gluten-free diet should be used for weight loss? J Am Diet Assoc 2011;111(11):1786.

18. Brottveit M, Beitnes AC, Tollefsen S, Bratlie JE, et al. Mucosal cytokine response after short-term gluten challenge in celiac disease and non-celiac gluten sensitivity. Am J Gastroenterol 2013;108:842-850.

19. Lisker R, Perez-Briseno R, Granados J, Babinsky V. Gene frequencies and admixture estimates in four Mexican urban centers. Hum Biol 1990;62:791.

20. Remes-Troche JM, Ramirez-Iglesias MT, Rubio-Tapia A. Celiac disease could be a frequent disease in Mexico: Prevalence of tissue transglutaminase antibody in healthy blood donors. J Clin Gastroenterol 2006;40:697-700.

21. Valcarce-Leon JC, Santiago-Lomeli M, Schmulson M. Seroprevalence of IgA antibodies to tissue transglutaminase in a university-based population study in Mexico City. Am J Gastroenterol 2005;100(Suppl 7):S96.

22. Mendez-Sanchez N, Zamora-Valdes N, Sanchez-Giron F. Seroprevalence of anti-gliadin and anti-endomysium antibodies in Mexican adults. Gastroenterology 2006;130(suppl 2):A-668.

23. Remes-Troche JM, Nuñez-Alvares C, Uscanga-Dominguez LF. Celiac disease in Mexican population: an update. Am J Gastroenterol 2013;108(2):283-4.

24. Remes-Troche JM, Rios-Vaca A, Ramírez-Iglesias MT, Rubio-Tapia A, Andrade-Zarate V, Rodríguez-Vallejo F, et al. High prevalence of celiac disease in Mexican Mestizo adults with type 1 diabetes mellitus. J Clin Gastroenterol 2008;42(5):460-5.

25. Worona L, Coyote N, Valencia P. Prevalencia de la enfermedad celiaca en un grupo de pacientes con diabetes mellitus tipo I del Hospital Infantil de México. Rev Mex Gastroenterol 2009; 74(Supl 2):67.

26. Remes-Troche JM, Sánchez-Vargas LA, Ríos-Gálvez S, González-Sicilia E, et al. Escrutinio de enfermedad celiaca en pacientes con diagnostico previo de infertilidad. un estudio prospectivo en población mexicana. Rev Gastroenterol Mex 2013;78 Supl 2:27-30.

27. Sánchez-Vargas LA, Thomas-Dupont P, Torres-Aguilera M, Azamar-Jacome AA, et al. Prevalence of celiac disease and related antibodies in patients diagnosed with irritable bowel syndrome according to the Rome III criteria. A casecontrol study. Neurogastroenterol Motil 2016;28(7):994- 1000.

28. Sánchez-Maza YJ, Ríos-Gálvez S, Aedo-Garcés MR, Meixueiro-Daza A, et al. Enfermedad celiaca y síndrome de Williams-Beuren. Estudio de la Primera Cohorte de Pacientes Mexicanos y sus Familiares. Rev Gastroenterol Mex 2013;78(Supl 2):31-62.

29. Remes-Troche JM, Aedo-Garcés MR, Azamar-Jacomé AA, Vivanco M, Meixueiro-Daza A, Roesch-Dietlen F, et al. Enfermedad celiaca y sensibilidad al gluten no celiaca (SGNC) en pacientes con dispepsia no investigada. un análisis prospectivo mediante serología y biopsia duodenal. Rev Gastroenterol Mex 2013;78(Supl 2):31-62.

30. Treviño-Torres LE, Aedo-Garcés MR, Azamar-Jacomé AA, Vivanco M, et al. Prevalencia de sensibilidad a la lactosa y al gluten en pacientes con diagnóstico de síndrome de intestino irritable de acuerdo a criterios de Roma III. Rev Gastroenterol Méx 2012;77(Supl 3):32.

31. Ontiveros N, López-Gallardo JA, Vergara-Jiménez MJ, Cabrera-Chávez F. Self-reported prevalence of symptomatic adverse reactions to gluten and adherence to gluten-free diet in an adult Mexican population. Nutrients 2015 21;7(7):6000-15.

32. Ludvigsson JF, Card TR, Kaukinen K, Bai J, et al. Screening for celiac disease in the general population and in high-risk groups. United European Gastroenterol J 2015;3(2):106-20.

33. Sugai E, Vázquez H, Nachman F, Moreno ML, et al. Accuracy of testing for antibodies to synthetic gliadin-related peptides in celiac disease. Clin Gastroenterol Hepatol 2006;4:1112-1117.

34. Sugai E, Moreno ML, Hwang HJ, Cabanne A, et al. Celiac disease serology in patients with different pretest probabilities: is biopsy avoidable? World J Gastroenterol 2010 7;16(25):3144-52.

35. Oberhuber G, Granditsch G, Vogelsang H. The histopathology of coeliac disease: time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol 1999;11:1185e94.

36. Escudero-Hernández C, Peña AS, Bernardo D. Immunogenetic pathogenesis of celiac disease and non-celiac gluten sensitivity. Curr Gastroenterol Rep 2016l;18(7):36.

37. Cheng J, Brar PS, Lee AR, Green PHR. Body mass index in celiac disease. Beneficial effect of a gluten-free diet. J Clin Gastroenterol 2010;44(4): 267-271.

38. Dickey W, Kearney N. Overweight in celiac disease: Prevalence, clinical characteristics, and effect of a gluten-free diet. Am J Gastroenterol 2006;101(10):2356-2359.

39. Tortora R, Capone P, De Stefano G, Imperatore N, Gerbino N, et al. Aliment Pharmacol Ther 2015;41(4):352-9.

40. van Loo J, Coussement P, de Leenheer L, Hoebregs H, Smits G. On the presence of inulin and oligofructose as natural ingredients in the Western diet. Crit Rev Food Sci Nutr 1995;35(6):525-552.

41. Moshfegh AJ, Friday JE, Goldman JP, Ahuja JKC. Presence of inulin and oligofructose in the diets of Americans. J Nutr 1999;129(7 suppl):1407S-1411S.

42. Harris KA, Kris-Etherton PM. Effects of whole grains on coronary heart disease risk. Curr Atheroscler Rep 2010;12(6):368-376.

43. Jenkins DJA, Kendall CWC, Vuksan V, et al. Effect of wheat bran on serum lipids: Influence of particle size and wheat protein. J Am Coll Nutr 1999;18(2):159-165.

44. Jenkins DJ, Kendall CW, Vuksan V, Augustin LS, et al. Highprotein diets in hyperlipidemia: Effect of wheat gluten on serum lipids, uric acid, and renal function. Am J Clin Nutr 2001;74(1):57-63.

45. Biesiekirski JR, Peters SL, Newnham ED, Rosella O. No effects of gluten in patients with self-reported non-celiac gluten sensitivity following dietary reduction of lowfermentable, poorly absorbed, short-chain carbohydrates. Gastroenterology 2013;145:320-328.

46. De Palma G, Nadal I, Collado MC, Sanz Y. Effects of a glutenfree diet on gut microbiota and immune function in healthy adult human subjects. Br J Nutr 2009;102(8):1154-1160.

47. Costabile A, Klinder A, Fava F, Napolitano A, et al. Wholegrain wheat breakfast cereal has a prebiotic effect on the human gut microbiota: A double blind, placebo-controlled, crossover study. Brit J Nutr 2008;99(1):110-120.

48. Novak F, Heyland DK, Avenall A, Drover JW, Su X. Glutamine supplementation in serious illness: A systematic review of the evidence. Crit Care Med 2002;30(9):2022-2029.

49. Horiguchi N, Horiguchi H, Suzuki Y. Effect of wheat gluten hydrolysate on the immune system in healthy human subjects. Biosci Biotechnol Biochem 2005;69(12):2445-2449.